Pathology review of thin melanoma and melanoma in situ in a multidisciplinary melanoma clinic: Impact on treatment decisions

Journal of Clinical Oncology

Volumn 28, Issue 3, 2010, Pages 481-486

  Santillan, Alfredo A ^a   Messina, Jane L ^a   Marzban, Suroosh S ^a   Crespo, Gema ^a   Sondak, Vernon K ^a   Zager, Jonathan S ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CENTER; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CARCINOMA IN SITU; CLINICAL ARTICLE; EARLY CANCER; FEMALE; HUMAN; MALE; MELANOMA; MELANOMA IN SITU; MITOSIS; MITOSIS RATE; PATIENT REFERRAL; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; TREATMENT PLANNING; ADOLESCENT; CHILD; COMPARATIVE STUDY; INFANT; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; SKIN TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA IN SITU; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SKIN NEOPLASMS; YOUNG ADULT;

EID: 75749124681     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.24.7734     Document Type: Article

References (29)

1. Ries LA, Wingo PA, Miller DS, et al: The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 88:2398-2424, 2000
2. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2009. CA Cancer J Clin 59:225-249, 2009
3. Gimotty PA, Botbyl J, Soong SJ, et al: A population-based validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 23:8065-8075, 2005
4. Johnson TM, Dolan OM, Hamilton TA, et al: Clinical and histologic trends of melanoma. J Am Acad Dermatol 38:681-686, 1998
5. Aitken JF, Janda M, Elwood M, et al: Clinical outcomes from skin screening clinics within a community-based melanoma screening program. J Am Acad Dermatol 54:105-114, 2006
6. Abbasi NR, Shaw HM, Rigel DS, et al: Early diagnosis of cutaneous melanoma: Revisiting the ABCD criteria. JAMA 292:2771-2776, 2004
7. Gabel M, Hilton NE, Nathanson SD: Multidisciplinary breast cancer clinics: Do they work? Cancer 79:2380-2384, 1997
8. Back MF, Ang EL, Ng WH, et al: Improvements in quality of care resulting from a formal multidisciplinary tumour clinic in the management of high-grade glioma. Ann Acad Med Singapore 36: 347-351, 2007
9. Johnson TM, Chang A, Redman B, et al: Management of melanoma with a multidisciplinary melanoma clinic model. J Am Acad Dermatol 42: 820-826, 2000
10. National Comprehensive Cancer Network: The NCCN Clinical Practice Guidelines in Oncology Melanoma (Version 2.2009). http://www.nccn.org
11. Balch CM, Buzaid AC, Soong SJ, et al: Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19:3635-3648, 2001
12. Kronz JD, Westra WH, Epstein JI: Mandatory second opinion surgical pathology at a large referral hospital. Cancer 86:2426-2435, 1999
13. Tomaszewski JE, LiVolsi VA: Mandatory second opinion of pathologic slides: Is it necessary? Cancer 86:2198-2200, 1999
14. Newman EA, Guest AB, Helvie MA, et al: Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board. Cancer 107:2346-2351, 2006
15. Khalifeh I, Taraif S, Reed JA, et al: A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: A potential misdiagnosis of melanoma in situ. Am J Surg Pathol 31:1130-1136, 2007
16. Gimotty PA, Elder DE, Fraker DL, et al: Identification of high-risk patients among those diagnosed with thin cutaneous melanomas. J Clin Oncol 25:1129-1134, 2007
17. Azzola MF, Shaw HM, Thompson JF, et al: Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: An analysis of 3661 patients from a single center. Cancer 97:1488-1498, 2003
18. Sondak VK, Taylor JM, Sabel MS, et al: Mitotic rate and younger age are predictors of sentinel lymph node positivity: Lessons learned from the generation of a probabilistic model. Ann Surg Oncol 11:247-258, 2004
19. Karim RZ, van den Berg KS, Colman MH, et al: The advantage of using a synoptic pathology report format for cutaneous melanoma. Histopathology 52:130-138, 2008
20. Murali R, Hughes MT, Fitzgerald P, et al: Interobserver variation in the histopathologic reporting of key prognostic parameters, particularly Clark level, affects pathologic staging of primary cutaneous melanoma. Ann Surg 249:641-647, 2009
21. Balch CM, Soong SJ, Gershenwald JE, et al: Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19:3622-3634, 2001
22. Balch CM, Soong SJ, Atkins MB, et al: An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin 54:131-149, 2004
23. Kesmodel SB, Karakousis GC, Botbyl JD, et al: Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas. Ann Surg Oncol 12:449-458, 2005
24. Patrick RJ, Corey S, Glass LF: The use of sequential serial sectioning of thin melanomas in determining maximum Breslow depth. J Am Acad Dermatol 57:S127-S128, 2007 (suppl 5)
25. Colloby PS, West KP, Fletcher A: Observer variation in the measurement of Breslow depth and Clark's level in thin cutaneous malignant melanoma. J Pathol 163:245-250, 1991
26. Krieger N, Hiatt RA, Sagebiel RW, et al: Interobserver variability among pathologists' evaluation of malignant melanoma: Effects upon an analytic study. J Clin Epidemiol 47:897-902, 1994
27. Corona R, Mele A, Amini M, et al: Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J Clin Oncol 14:1218-1223, 1996
28. Scolyer RA, Shaw HM, Thompson JF, et al: Interobserver reproducibility of histopathologic prognostic variables in primary cutaneous melanomas. Am J Surg Pathol 27:1571-1576, 2003
29. McDermott NC, Hayes DP, al-Sader MH, et al: Identification of vertical growth phase in malignant melanoma: A study of interobserver agreement. Am J Clin Pathol 110:753-757, 1998